SPRUCE BIOSCIENCES, INC.
SPRBDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
5wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How SPRB's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SPR001 | Phase 2 | Congenital Adrenal Hyperplasia | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in SPRUCE BIOSCIENCES, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in SPRUCE BIOSCIENCES, INC.'s (SPRB) pipeline across Phase 2. Its lead program is SPR001 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SPRUCE BIOSCIENCES, INC.'s next FDA catalyst?→
SPRUCE BIOSCIENCES, INC.'s (SPRB) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track SPRB biotech catalysts?→
Add SPRB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SPRUCE BIOSCIENCES, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.